Wells Fargo lowered the firm's price target on Doximity to $32 from $45 and keeps an Overweight rating on the shares. Negative sentiment appears to reflect risks to market growth and pressure on wallet share, the firm says, adding that both appear priced in. With that said, Wells' recent key opinion leader call points to share stability alongside improving market ad growth.